Navigation Links
Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
Date:2/12/2008

PALO ALTO, Calif., Feb. 12 /PRNewswire/ -- Nfocus Neuromedical, Inc. today announced that the company has received CE mark approval for the CardioVasc(TM) Stent-Graft and Delivery System. The CardioVasc(TM) Stent-Graft is a minimally invasive device for treating patients with Saphenous Vein Graft Lesions (SVGs) from a previous coronary bypass, Vessel Perforations and Coronary Artery Aneurysms. The CE mark allows Nfocus to begin marketing the CardioVasc(TM) Stent-Graft in the European Union, and indicates that the product complies with the appropriate quality and safety standards.

"We are pleased to be able to offer this valuable option to physicians in the European Union for treating diseased bypass grafts. This is an important first step in what we hope to be a series of regulatory approvals in the coming year," said Martin Dieck, President and CEO of Nfocus Neuromedical, Inc.

Saphenous Vein Graft Disease

Saphenous vein graft (SVG) disease has been a problem facing the cardiologist since the early days of coronary artery bypass graft (CABG) surgery. In CABG surgery, a segment of the patient's own leg vein (the "saphenous vein") may be removed and used to create an artificial conduit to bypass areas of blood flow blockage (also known as stenosis or plaque) that have built up in the patient's coronary artery. After CABG surgery, this SVG bypass itself may become blocked over time by the same type of disease that affected the patient's original coronary artery. The result is a need to reopen the diseased SVG vessel and restore flow. This second treatment again can be yet another surgery -- or alternatively, the SVG may be treated via angioplasty and stenting procedures using less-invasive endovascular (catheter) techniques. The CardioVasc(TM) Stent-Graft device is a permanent implant delivered via a less-invasive catheter procedure for patients that have a diseased SVG from a previous CABG surgery. The CardioVasc(TM) Stent-Graft is not appr
'/>"/>

SOURCE Nfocus Neuromedical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...it lowered bad cholesterol more effectively than Z...s) -- After nearly a year of review, U.S. health o...tinued use of the controversial cholesterol-loweri...istration said there was no significant difference...ng Vytorin and patients taking the drug Zocor. ,...
(Date:1/8/2009)... of local dance students will dance to raise money...POLIS, Jan. 8 , , , WHO: ...ll show off their talent in the 3rd annual Dance,...y Dance Arts Centre. The, event w...or., Participants raise money th...
(Date:1/8/2009)...AGO, Jan. 8 Allscripts-M...pts Healthcare Solutions, Inc. (Allscripts or,the...or the three and six,months ended November 30, 20...n/prnh/20061005/ALLSCRIPTSLOGO-b ) , The Co... November 30, 2008,include results from legacy Al...
(Date:1/8/2009)...FRANCISCO, Jan. 8 Mediva... David Hung, M.D., president and chief,executive ...an Healthcare,Conference on Wednesday, January 14...ancis Hotel in San Francisco. , Dr. Hung wi...cal,development programs for Dimebon for Alzheime...
Breaking Medicine News(10 mins):Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Dance With Courage to Benefit Camp Courage 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
...ement has fuelled a booming industry and turned pl...than 22,000 operations were carried out on men and.... The number of women // opting for cosmetic surge...interest also increased, particularly for facial a...
...history of heart problems and consume anti-impoten...ng their eyesight damaged, according to a study co...chers suggest that taking viagra may result in the...ow, giving rise to tissue damage. The British Medi...
... increase in the incidence of Polio in Bihar state...tate health officials. The state stands unparalle... country. // A massive polio immunization programm...ildren less than 5 years of age has been launched ...
...lu pandemic is on the rise as there are new report...agglutinin antigen fragment of the bird flu virus ...e to antiflu drugs shown by these viruses. Scienti..., in which the antibodies is collected from the bl...
Other Medicine News:Health News:UK Plastic surgeons cash in as cosmetic operations soar 2Health News:UK Plastic surgeons cash in as cosmetic operations soar 3Health News:Bihar Health Officials Worried As Polio Cases Soar 2
(Date:1/6/2009)...BRIDGE, Mass., Jan. 6 Cequent Phar... products to deliver RNAi-based treatments to prev...mpany has recently completed a successful toxicolo...stered tk RNAi therapeutic targeting the primary ...denomatous polyposis). FAP is an inherited gastroi...
(Date:1/5/2009)... SAN JOSE, Calif., Jan. 5 Women un...gesterone medication to help support early,pregna...ms of this medication,can be painful for patients...can be administered by subcutaneous injection or v... better patient tolerance. , With patient w...
(Date:12/27/2008)... SAN DIMAS, Calif., Dec. 27 Accord... are best advised to consume modest doses of,resv...typically provided in 3,to 5 glasses of aged, red...oto: http://www.newscom.com/cgi-bin/prnh/2008060...mega-dose resveratrol alone fails to prolong,the ...
(Date:12/17/2008)...TO, Calif., Dec. 17 PEAK Surgical,...d a new tissue dissection system based on a,propr...ood and Drug,Administration (FDA) has granted the...urgery System for cutting and coagulation of soft ...r, nose and throat), gynecologic,orthopedic, art...
Breaking Medicine Technology:Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4EntreMed Teams with JSB Partners to Expedite Partnering of its Aurora Kinase Program 25323 1EntreMed Teams with JSB Partners to Expedite Partnering of its Aurora Kinase Program 25323 2EntreMed Teams with JSB Partners to Expedite Partnering of its Aurora Kinase Program 25323 3Concentric Medical 28R 29 Announces Co Marketing Agreement With InTouch Health 28R 29 to Advance Acute Ischemic Stroke Care 7088 1Concentric Medical 28R 29 Announces Co Marketing Agreement With InTouch Health 28R 29 to Advance Acute Ischemic Stroke Care 7088 2MabVax Therapeutics Closes Two Licensing Agreements With Sloan Kettering Institute for Cancer Research 2820 1MabVax Therapeutics Closes Two Licensing Agreements With Sloan Kettering Institute for Cancer Research 2820 2Dermatologists Score Healthy First for Fans at Final Tennis Tournament Before U S Open 25320 1Dermatologists Score Healthy First for Fans at Final Tennis Tournament Before U S Open 25320 2Dermatologists Score Healthy First for Fans at Final Tennis Tournament Before U S Open 25320 3
...ering-Plough Announces Presentation Of Phase II Tr...onist At The 2007 Annual,Meeting Of The American C...March 16, 2007 /PRNewswire-FirstCall/ --,Schering-... the,Phase II trial of its novel oral thrombin rec...d at the 2007 annual Scientific Sessions,of the of...
...N CARLOS, Calif., March 19, 2007 /PRNewswire-First...l data from the ANTHEM,(Anticoagulation with rNAPc...oking at recombinant nematode anticoagulant protei...ute coronary syndromes,(NSTE-ACS) will be presente...(ACC) 56th Annual Scientific Session taking place ...
Other Medicine Technology:Media Advisory: ACC Updated Schedule 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 3
The 15 and 18 Sony Flat Screen Monitors with articulating arm can be used in conjunction with existing surgical monitors or as replacements.
Colour video monitors.
The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty.
Camera and light source in one compact "Plug-and-Play" device.
Medicine Products: